Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells

Human Immunology

Volumn 74, Issue 3, 2013, Pages 395-401

  Noguchi, Satoshi ^a,b   Hamano, Emi ^a,b   Matsushita, Ikumi ^a   Hijikata, Minako ^a   Ito, Hideyuki ^a   Nagase, Takahide ^b   Keicho, Naoto ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; CELL DNA; LEUKOCYTE ELASTASE; RNA;

ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; EPITHELIUM CELL; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

2',5'-OLIGOADENYLATE SYNTHETASE; ALTERNATIVE SPLICING; BRONCHI; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HUMANS; IMMUNOBLOTTING; INTERFERON-BETA; ISOENZYMES; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICE SITES; TRANSCRIPTION, GENETIC;

EID: 84873711628     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.11.011     Document Type: Article

References (33)

1. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89:1-47.
2. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8:559-568.
3. Hovanessian A.G., Justesen J. The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. Biochimie 2007, 89:779-788.
4. Kristiansen H., Gad H.H., Eskildsen-Larsen S., Despres P., Hartmann R. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res 2011, 31:41-47.
5. Chakrabarti A., Jha B.K., Silverman R.H. New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res 2011, 31:49-57.
6. Justesen J., Hartmann R., Kjeldgaard N.O. Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci 2000, 57:1593-1612.
7. Ghosh A., Sarkar S.N., Rowe T.M., Sen G.C. A specific isozyme of 2'-5' oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. J Biol Chem 2001, 276:25447-25455.
8. Domingo-Gil E., Esteban M. Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved. Apoptosis 2006, 11:725-738.
9. Castelli J.C., Hassel B.A., Maran A., Paranjape J., Hewitt J.A., Li X.L., et al. The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ 1998, 5:313-320.
10. Bonnevie-Nielsen V., Field L.L., Lu S., Zheng D.J., Li M., Martensen P.M., et al. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 2005, 76:623-633.
11. Burgner D., Jamieson S.E., Blackwell J.M. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?. Lancet Infect Dis 2006, 6:653-663.
12. Mashimo T. A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 2002, 99:11311-11316.
13. Perelygin A.A. Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA 2002, 99:9322-9327.
14. Lim J.K., Lisco A., McDermott D.H., Huynh L., Ward J.M., Johnson B., et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 2009, 5:e1000321.
15. Knapp S., Yee L.J., Frodsham A.J., Hennig B.J., Hellier S., Zhang L., et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 2003, 4:411-419.
16. Lin R.J., Yu H.P., Chang B.L., Tang W.C., Liao C.L., Lin Y.L. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection. J Immunol 2009, 183:8035-8043.
17. Hamano E., Hijikata M., Itoyama S., Quy T., Phi N.C., Long H.T., et al. Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun 2005, 329:1234-1239.
18. Gray T.E., Guzman K., Davis C.W., Abdullah L.H., Nettesheim P. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 1996, 14:104-112.
19. Lalonde E., Ha K.C., Wang Z., Bemmo A., Kleinman C.L., Kwan T., et al. RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression. Genome Res 2011, 21:545-554.
20. Cagliani R., Fumagalli M., Guerini F.R., Riva S., Galimberti D., Comi G.P., et al. Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis. Hum Genet 2012, 131:87-97.
21. Leong D.T., Gupta A., Bai H.F., Wan G., Yoong L.F., Too H.P., et al. Absolute quantification of gene expression in biomaterials research using real-time PCR. Biomaterials 2007, 28:203-210.
22. A haplotype map of the human genome. Nature 2005, 437:1299-1320.
23. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
24. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
25. Benech P., Merlin G., Revel M., Chebath J. 3' end structure of the human (2'-5') oligo A synthetase gene: prediction of two distinct proteins with cell type-specific expression. Nucleic Acids Res 1985, 13:1267-1281.
26. Chebath J., Benech P., Hovanessian A., Galabru J., Revel M. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. J Biol Chem 1987, 262:3852-3857.
27. Pickrell J.K., Marioni J.C., Pai A.A., Degner J.F., Engelhardt B.E., Nkadori E., et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 2010, 464:768-772.
28. Rotger M., Dang K.K., Fellay J., Heinzen E.L., Feng S., Descombes P., et al. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog 2010, 6:e1000781.
29. Glisovic T., Bachorik J.L., Yong J., Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett 2008, 582:1977-1986.
30. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379.
31. Heinzen E.L., Ge D., Cronin K.D., Maia J.M., Shianna K.V., Gabriel W.N., et al. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 2008, 6:e1.
32. Suzuki T., Yamashita C., Zemans R.L., Briones N., Van Linden A., Downey G.P. Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway. Am J Respir Cell Mol Biol 2009, 41:742-755.
33. Kaminskyy V., Zhivotovsky B. To kill or be killed: how viruses interact with the cell death machinery. J Intern Med 2010, 267:473-482.